COPD: LPS neutrophil chemotaxis model (systemic)
A key hallmark of Sepsis is systemic inflammation.
Validated positive control is the oral steroid Dexamethasone.
Study Design | |
---|---|
Species/Strain | SD rat, Balb/c mouse |
Model | Systemic LPS neutrophil chemotaxis model |
Relevant Use | Screening new candidate drugs for the reduction of systemic inflammation |
Readouts Available | Systemic cytokines |
Study data generated by Labcorp Huntingdon Pharmacology.
Related Models
-
Bhas 42 Cell Transformation Assay (CTA)
Carcinogenicity, Discovery, Toxicology -
Asthma: Ovalbumin sensitization and challenge
Discovery -
Chlorine Induced Lung Injury
Discovery -
COPD: LPS + fMLP PK/PD model – Neutrophil Elastase Targets
Discovery -
COPD: Human Neutrophil Elastase Lung Hemorrhage Model
Discovery -
Bronchoconstriction models for LABA, LAMA & MABAs
Discovery -
Flu Model: H1N1 influenza lung infection model – viral COPD exacerbation
Discovery -
Model of Allergic Bronchopulmonary Aspergillosis (ABPA) in Mice
Discovery